Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Apple

Bank of America

Intel

Taiwan Semiconductor Manufacturing

Should investors be considering these top dividend-paying stocks now?

5 Dividend Stocks For January 2022

CVS Health Corp (NYSE: CVS) boosted its 2021 guidance ahead of its fourth-quarter earnings in early February, with executives citing better-than-expected performance in its retail segment. In an SEC filing, the Company raised its full-year earnings projections to $8.33 - $8.38 per share from a previous estimate of $8.

Amid Stronger Than Expected Retail Performance, CVS Health Boosts 2021 Guidance

CVS Health Corporation (CVS) CEO Karen Lynch presents at JPMorgan 40th Annual Healthcare Conference - Transcript

CVS raised its 2021 earnings forecast, citing higher demand for COVID-19 vaccinations and over-the-counter testing as infections in the US soared.

CVS ups profit forecast as demand for COVID vaccines, tests rises

When I first wrote my bull thesis about CVS Health on Aug 15, 2021, the price was so attractive that I recommended a leverage play using call options. Since then, the total return has been almost 25% and some readers asked if the bull thesis is over or not.

CVS Health: Still Time To Buy It Near Cyclical Low

CVS Health raised its full-year 2021 earnings outlook as the drugstore chain's customers race to get vaccinated against Covid-19 or tested for the virus as the Omicron variant surges across the U.S.

Covid Vaccines And Testing Boost CVS Health Earnings Outlook

While the ongoing spread of the omicron variant of COVID-19 across the U.S. and around the world has severely hampered the retail sector and forced the corporate and education worlds to rethink their plans, it's meant big business for CVS Health and other companies focused on healthcare. CVS Health raised its full-year earnings guidance Tuesday […]

CVS Health Announces Elevated Earnings Outlook Amid Omicron Variant Spread

CVS Health Corp on Tuesday raised its adjusted earnings forecast for 2021, citing strong retail sales helped by higher demand for COVID-19 vaccines as well as over-the-counter testing in November and December.

CVS raises 2021 profit view as COVID-19 vaccines, tests drive retail strength

The pharma company expects adjusted earnings to be in the range of $8.33 to $8.38, higher than previous guidance.

CVS Lifts 2021 Earnings Outlook, Sticks With 2022 View

CVS Health said Tuesday ahead of a presentation with investors that it has raised its full-year earnings outlook.

CVS Health raises 2021 earnings outlook, backs 2022 forecast

CVS Health Corp. CVS, +0.84% said Tuesday it expects to earn between $5.87 and $5.92 a share in 2021, up from its earlier guidance of $5.50 to $5.61. The company now expects full year 2021 adjusted earnings of $8.33 to $8.38 a share, up from its earlier view for earnings of at least $8 a share.

CVS Health hikes 2021 earnings range and backs 2022 view

Lennar

Here are a pair of long trading recommendations for a moderately stronger week.

Stocks This Week: Buy CVS Health Corporation And Lennar Corporation

WOONSOCKET, R.I., Jan. 6, 2022 /PRNewswire/ -- CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 9, 2022, at 8:00 a.m.

CVS Health to Hold Fourth Quarter and Full Year 2021 Earnings Conference Call

Disney

Alphabet

Exxon Mobil

Five macro themes investors need to keep in mind when investing for 2022. Five suggested stocks to buy related to those themes and valuations. GOOG, CVS, DIS, FB and XOM are a buy and will provide your portfolio a boost for 2022.

5 Secular Trends And Stock Picks For 2022

CVS Health (CVS) closed at $104.16 in the latest trading session, marking a +0.97% move from the prior day.

CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know

AbbVie

ARK Innovation ETF

Brunswick

Celanese

Crane Company

Evercore

Fortune Brands Home & Security

Huntington Bancshares

Kroger

Lowe's

Altria

Realty Income Corp

Schwab US Dividend Equity ETF

First Trust SMID Cap Rising Dividend Achievers ETF

Sherwin-Williams

Snap-on

AT&T

Universal Forest Products

Vanguard Dividend Appreciation ETF

Vanguard High Dividend Yield ETF

Whirlpool

Worthington Industries

Williams-Sonoma

We start out with a short list of guidelines that make it easier to identify dividend stocks that are still worth investing in right now.

The Best Dividend Stocks For January 2022

Amgen

Merck

All three companies rewarded shareholders with significant payout increases.

These 3 Stocks Just Hiked Their Dividends: Should You Buy Them?

Cloudera

Cerence

Dick's Sporting Goods

Home Depot

Cloudflare

Nuance Communications

Target

Trade Desk

TDK Corp

Walmart

Some "CEO of the Year" Nominees for 2021

WOONSOCKET, R.I., Dec. 22, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that President and CEO Karen S.

CVS Health to Present at the 40th Annual J.P. Morgan Healthcare Conference

Abbott Labs

Automatic Data Processing

Aflac

Broadcom

Best Buy

Simon Property Group

Total income will finish 2021 at $13,662, an increase of 13.9% over the previous year.

My Dividend Growth Portfolio Final 2021 Recap - Record Growth And A New Position Established

BorgWarner

Eastman Chemical

Every year, the major Wall Street firms we cover here at 24/7 Wall St. come out with their lists of stocks that they feel will be the top performers for the coming year.

BofA Securities Out With Its 11 Top Stock Picks for 2022

News for CVS Health Stock (CVS)